JP2007502790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502790A5 JP2007502790A5 JP2006523577A JP2006523577A JP2007502790A5 JP 2007502790 A5 JP2007502790 A5 JP 2007502790A5 JP 2006523577 A JP2006523577 A JP 2006523577A JP 2006523577 A JP2006523577 A JP 2006523577A JP 2007502790 A5 JP2007502790 A5 JP 2007502790A5
- Authority
- JP
- Japan
- Prior art keywords
- active substance
- excipients
- excipient
- inhalable powder
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ITIXDWVDFFXNEG-JHOUSYSJSA-N NCCCC[C@@H](C(N(CC1)CCN1c1ccncc1)=O)NC([C@@H](Cc(cc1Br)cc(Br)c1O)NC(N(CC1)CCC1N(Cc(cccc1)c1N1)C1=O)=O)=O Chemical compound NCCCC[C@@H](C(N(CC1)CCN1c1ccncc1)=O)NC([C@@H](Cc(cc1Br)cc(Br)c1O)NC(N(CC1)CCC1N(Cc(cccc1)c1N1)C1=O)=O)=O ITIXDWVDFFXNEG-JHOUSYSJSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10338399A DE10338399A1 (de) | 2003-08-18 | 2003-08-18 | Mikropartikel, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-Iysyl]-4-(4-pyridinyl)-piperazin, Verfahren zu deren Herstellung sowie deren Verwendung als Inhalaltionspulver |
| DE10338399.9 | 2003-08-18 | ||
| PCT/EP2004/009013 WO2005018609A1 (de) | 2003-08-18 | 2004-08-12 | Mikropartikel, enthaltend den cgrp-antagonisten 1- [n2-[3,5-dibrom-n-[[4-(3,4-dihydro-2(1h)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazin, verfahren zu deren herstellung sowie deren verwendung als inhalationspulver |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007502790A JP2007502790A (ja) | 2007-02-15 |
| JP2007502790A6 JP2007502790A6 (ja) | 2007-05-10 |
| JP2007502790A5 true JP2007502790A5 (https=) | 2007-09-27 |
Family
ID=34201779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523577A Pending JP2007502790A (ja) | 2003-08-18 | 2004-08-12 | Ｃｇｒｐアンタゴニスト１−〔ｎ２−〔３，５−ジブロモ−ｎ−〔〔４−（３，４−ジヒドロ−２（１ｈ）−オキソキナゾリン−３−イル）−１−ピペリジニル〕カルボニル〕−ｄ−チロシル〕−ｌ−リシル〕−４−（４−ピリジニル）−ピペラジンを含む微粒子、その調製方法及び吸入粉末としてのその使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1658051A1 (https=) |
| JP (1) | JP2007502790A (https=) |
| CA (1) | CA2536048A1 (https=) |
| DE (1) | DE10338399A1 (https=) |
| UY (1) | UY28474A1 (https=) |
| WO (1) | WO2005018609A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10338402A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| DE10338407A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Inhalationspulver enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin |
| EP3673895A1 (en) * | 2018-12-28 | 2020-07-01 | Université Libre de Bruxelles | Dry powder inhalation formulation and its use for the therapeutic treatment of lungs |
| WO2024211881A1 (en) * | 2023-04-06 | 2024-10-10 | Navinta, Llc | Rimegepant suspension |
| WO2024220974A1 (en) * | 2023-04-21 | 2024-10-24 | Navinta, Llc | Rimegepant fast-dissolving films for oral administration |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
| DE19937304C2 (de) * | 1999-08-10 | 2003-08-21 | Boehringer Ingelheim Pharma | Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
| AU2001230533A1 (en) * | 2000-02-04 | 2001-08-14 | Kissei Pharmaceutical Co. Ltd. | Powdered preparation for inhalation and powder inhalant containing the same packed |
| GB0014851D0 (en) * | 2000-06-16 | 2000-08-09 | Glaxo Group Ltd | Novel pharmaceutical formulation |
| DE10139410A1 (de) * | 2001-08-17 | 2003-02-27 | Boehringer Ingelheim Pharma | Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
| DE10206770A1 (de) * | 2002-02-19 | 2003-08-28 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096 |
| DE10207026A1 (de) * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung |
| DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| DE10338402A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| DE10338407A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Inhalationspulver enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin |
-
2003
- 2003-08-18 DE DE10338399A patent/DE10338399A1/de not_active Withdrawn
-
2004
- 2004-08-12 WO PCT/EP2004/009013 patent/WO2005018609A1/de not_active Ceased
- 2004-08-12 JP JP2006523577A patent/JP2007502790A/ja active Pending
- 2004-08-12 EP EP04764017A patent/EP1658051A1/de not_active Withdrawn
- 2004-08-12 CA CA002536048A patent/CA2536048A1/en not_active Abandoned
- 2004-08-17 UY UY28474A patent/UY28474A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502789A5 (https=) | ||
| JP2007502789A (ja) | 噴霧乾燥された無定形ｂｉｂｎ４０９６、その調製方法及び吸入剤としてのその使用 | |
| JP2007502789A6 (ja) | 噴霧乾燥された無定形ｂｉｂｎ４０９６、その調製方法及び吸入剤としてのその使用 | |
| US20050043247A1 (en) | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative | |
| US11872314B2 (en) | Pharmaceutical compositions | |
| US6900317B2 (en) | Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them | |
| TWI468190B (zh) | 具有改良之安定性的（ｚ）－２－氰基－３－羥基－丁－２－烯酸－（４’－三氟甲基苯基）－醯胺錠劑調配物 | |
| US6692768B1 (en) | Preparation method of drug-containing spherical fine particles | |
| JP4085064B2 (ja) | Ｃｇｒｐ拮抗剤ｂｉｂｎ４０９６の塩を含有する吸入粉末の調製方法 | |
| JP2005538934A5 (https=) | ||
| CN102946868A (zh) | 包含抗毒蕈碱药的干粉制剂 | |
| JP2007502790A5 (https=) | ||
| JP2019502697A (ja) | 呼吸域ザフィルルカスト粒子の調製方法 | |
| KR20210070968A (ko) | 닌테다닙 또는 이의 약학적으로 허용가능한 염의 미세입자를 포함하는 흡입용 건조분말 제형 | |
| WO2012002547A1 (ja) | ボセンタン固体分散体 | |
| US20060165787A1 (en) | Ceramic structures for controlled release of drugs | |
| JP5615612B2 (ja) | 苦味を有する生理活性物質含有粒子の製造方法 | |
| US20050042178A1 (en) | Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder | |
| JP2007502790A (ja) | Ｃｇｒｐアンタゴニスト１−〔ｎ２−〔３，５−ジブロモ−ｎ−〔〔４−（３，４−ジヒドロ−２（１ｈ）−オキソキナゾリン−３−イル）−１−ピペリジニル〕カルボニル〕−ｄ−チロシル〕−ｌ−リシル〕−４−（４−ピリジニル）−ピペラジンを含む微粒子、その調製方法及び吸入粉末としてのその使用 | |
| JP2007502790A6 (ja) | Ｃｇｒｐアンタゴニスト１−〔ｎ２−〔３，５−ジブロモ−ｎ−〔〔４−（３，４−ジヒドロ−２（１ｈ）−オキソキナゾリン−３−イル）−１−ピペリジニル〕カルボニル〕−ｄ−チロシル〕−ｌ−リシル〕−４−（４−ピリジニル）−ピペラジンを含む微粒子、その調製方法及び吸入粉末としてのその使用 | |
| JP2007502792A5 (https=) | ||
| CN1638728A (zh) | 含有cgrp拮抗剂[bibn4096]的粉末吸入剂及其制备 | |
| JP5356323B2 (ja) | 新規な非晶質ボセンタン及びその製造方法 | |
| JP2008525510A (ja) | 更年期ホットフラッシュを抑制するための特定のｃｇｒｐ拮抗薬の使用 | |
| JP2007502791A5 (https=) |